the addition of several new agents to the algorithms of therapy against rheumatoid arthritis raises questions about their effects and place in therapeutic regimens , especially as concerns auranofin , sulphasalazine , methotrexate and cyclosporin .
C0003873
rheumatoid arthritis
C0004320
auranofin